A carregar...

4-[4-(4-Fluoro­phen­yl)-2-methyl-5-oxo-2,5-dihydro­isoxazol-3-yl]-1-methyl­pyridinium iodide–4-[3-(4-fluoro­phen­yl)-2-methyl-5-oxo-2,5-dihydro­isoxazol-4-yl]-1-methyl­pyridinium iodide (0.6/0.4)

The crystal structure of the title compound, C(16)H(16)FN(2)O(2) (+)·I(−), was determined as part of a study of the biological activity of isoxazolone derivatives as p38 mitogen-activated protein kinase (MAPK) inhibitors. The X-ray crystal structure of 4-[4-(4-fluoro­phenyl)-2-methyl-5-oxo-2,5-dihyd...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Margutti, Simona, Schollmeyer, Dieter, Laufer, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: International Union of Crystallography 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2915348/
https://ncbi.nlm.nih.gov/pubmed/21200862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1107/S1600536807055985
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!